An observational study in Cataract and Myopia, sponsored by Chang Gung Memorial Hospital. Completed at 2 sites in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2026-10-06.
Sponsored by Chang Gung Memorial Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Cataract with a site in Taiwan — 2 open to participants now, 2 under way, none of them phase 3. Cataract · Taiwan.
Among the 15 studies in Cataract with a site in Taiwan, this one is one of 3 that started in 2025, is one of 6 observational ones, and was the 12th registered.
1,633 studies on the registry are indexed under Cataract; 234 are open to participants now.
Browse Cataract studies →2 of the 15 studies in Cataract with a site in Taiwan are open now. Recruiting first, the newest first:
National Taiwan University Hospital · Sites in Taiwan
Ages 18+ · Healthy volunteers
National Taiwan University Hospital · Sites in Taiwan
Ages 18–80
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 143 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 15 take healthy volunteers.
This study: 20 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 60 is below the median of 90 across 477 observational studies indexed under Cataract.
Median enrollment 60 across the 9 interventional studies, 111 across the 6 observational. Of the 13 that completed or were terminated, 1 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 15 have an industry lead sponsor. The 6 most frequent:
Chang Gung Memorial Hospital is the lead sponsor of 1,098 studies on the registry; 241 are open to participants now.
Chang Gung Memorial Hospital has 4 studies filed under Cataract — fewer than ten, so there is no comparison to draw.
1 of the studies in Cataract with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07693829National Taiwan University HospitalA Study on the Application of Smart Bed-Exit Alert Assistive Devices for Detecting Preoperative Bed Exits in Ophthalmic Surgery Patients in the Operating Room | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 15 studies in Cataract with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This trial hypothesized that novel laser refractive surgery techniques (LASIK, KLEx) or laser-assisted cataract surgery (FLACAS) could suppress postoperative inflammation and improve recovery in patients by reducing oxidative stress generated by the surgical procedure. It is also intended to verify whether the new laser technology is necessary for clinical use in groups with low antioxidant activity through the detection of antioxidant activity in the eyes of patients.
Simultaneously measure total reactive oxygen species (ROS), antioxidant capacity (TAC) and ascorbic acid (AA) in aqueous humor (cataract surgery only) or tears. All patients underwent the same examination at our institution, including uncorrected visual acuity (UCVA), intraocular pressure (IOP), as well as central corneal thickness (CCT) with pneumatic tonometer, apparent refraction with autorefractor, and corneal curvature with keratometer. The axial length (AXL), anterior chamber depth (ACD) and lens thickness (LT) were measured by optical biometer.
This study included patients with the following conditions: (1) at least 20 years old, (2) expected to undergo corneal refractive surgery or cataract surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Femtosecond-LASIK in myopia
Kerato-lenticule Extraction in myopia
Cataract Surgery with Phacoemulsification
Cataract Surgery with LenSx Femtosecond Laser
TAC in tears at 1 week
Change of Total Antioxidant Capacity (TAC) from Baseline to 1 week after surgery.
Time frame: Before the operation and 1 week after surgery.
TAC in tears at 1 month
Change of Total Antioxidant Capacity (TAC) from Baseline to 1 month after surgery.
Time frame: Before the operation and 1 month after surgery.
TAC in tears at 2 months
Change of Total Antioxidant Capacity (TAC) from Baseline to 2 months after surgery.
Time frame: Before the operation and 2 months after surgery.
TAC in tears at 3 months
Change of Total Antioxidant Capacity (TAC) from Baseline to 3 months after surgery.
Time frame: Before the operation and 3 months after surgery.
AA in tears at 1 week
Change of Ascorbic Acid (AA) from Baseline to 1 week after surgery.
Time frame: Before the operation and 1 week after surgery.
AA in tears at 1 month
Change of Ascorbic Acid (AA) from Baseline to 1 month after surgery.
Time frame: Before the operation and 1 month after surgery.
AA in tears at 2 months
Change of Ascorbic Acid (AA) from Baseline to 2 months after surgery.
Time frame: Before the operation and 2 months after surgery.
AA in tears at 3 months
Change of Ascorbic Acid (AA) from Baseline to 3 months after surgery.
Time frame: Before the operation and 3 months after surgery.
ROS in tears at 1 week
Change of Reactive Oxygen Species (ROS) from Baseline to 1 week after surgery.
Time frame: Before the operation and 1 week after surgery.
ROS in tears at 1 month
Change of Reactive Oxygen Species (ROS) from Baseline to 1 month after surgery.
Time frame: Before the operation and 1 month after surgery.
ROS in tears at 2 months
Change of Reactive Oxygen Species (ROS) from Baseline to 2 moths after surgery.
Time frame: Before the operation and 2 months after surgery.
ROS in tears at 3 months
Change of Reactive Oxygen Species (ROS) from Baseline to 3 months after surgery.
Time frame: Before the operation and 3 months after surgery.
TAC in aqueous humor at the next day
Change of Total Antioxidant Capacity (TAC) in aqueous humor from Baseline to one day after surgery
Time frame: Before the operation and one day after surgery.
AA in aqueous humor at the next day
Change of Ascorbic Acid (AA) in aqueous humor from Baseline to one day after surgery
Time frame: Before the operation and one day after surgery.
ROS in aqueous humor at the next day
Change of Reactive Oxygen Species (ROS) in aqueous humor from Baseline to one day after surgery
Time frame: Before the operation and one day after surgery.
BCVA
Examination of best corrected visual acuity (BCVA)
Time frame: Before surgery
UCVA at 1 week
Examination of uncorrected visual acuity (UCVA)
Time frame: 1 week after surgery
UCVA at 1 month
Examination of uncorrected visual acuity (UCVA)
Time frame: 1 month after surgery
UCVA at 2 months
Examination of uncorrected visual acuity (UCVA)
Time frame: 2 months after surgery
UCVA at 3 months
Examination of uncorrected visual acuity (UCVA)
Time frame: 3 months after surgery
Ran from Mar 2025 to primary completion in Oct 2025, 6 months.
Of 169 non-industry observational studies under Cataract, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 30. This study's 6 months is below that.
Counting every sponsor, half of 236 studies reached it within 16 months; a quarter within 9 and three quarters within 30.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 6, 2026: primary completion Nov 2025 → Oct 2025 and completion Nov 2025 → Mar 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chang Gung Memorial Hospital →